WebMay 1, 2024 · The host immune response is a potent defense mechanism against cancer development and progression. ... allowing 30–70% of the mice to be used as non-responders to anti-PD-1 therapy to identify the determinants of immunotherapy response. ... identifying the drivers of transcription deregulation that cause intrinsic or acquired … WebFeb 17, 2024 · CAR-T cells are a promising new treatment for B cell malignancies. However, the majority of patients inevitably go on to experience disease relapse through largely unknown means. To investigate leukemia-intrinsic CAR-T resistance mechanisms, we performed genome-wide CRISPR-Cas9 loss-of-function screening in an …
Tumor intrinsic and extrinsic determinants of response
WebJan 14, 2016 · This supports the observation that viral factors are critical determinants of responses to IFN treatment. To further investigate the intrinsic viral factors that determine viral response to IFN treatment, we performed sequencing analysis using the next-generation sequencing technology. WebApr 10, 2024 · The physiological response to the stressor is governed by PR. Long-term outcomes such as physical and cognitive functions, and clinical outcomes will be better for organisms with larger PR. Figure 1 also shows the pre-determinants of PR including age, psychosocial factors, health behaviors, genetics, and diseases. We hypothesize that the … higher sla
Tumor-intrinsic and -extrinsic determinants of response …
WebOct 10, 2024 · The genetic status of the tumor is one of the primary determinants of response to treatment with immune checkpoint inhibitors ... it should be noted that our rapidly evolving knowledge on the factors associated with response to ICB --both host-intrinsic and -extrinsic factors-- demonstrates the high level of complexity of interactions … WebSep 1, 2024 · To generate a more granular understanding of the genomic and immunologic determinants of the PD-1 response in MSI-H gastric cancer, we conducted a phase II trial in which we newly enrolled 19 … WebApr 6, 2024 · Genomic and transcriptomic analysis of 393 non-small cell lung cancer patients treated with checkpoint inhibitors identifies molecular features associated with response. higher size